![]() | Up a level |
Number of items: 1.
Sargeant, Jack A, King, James A, Yates, Thomas, Redman, Emma L, Bodicoat, Danielle H, Chatterjee, Sudesna, Edwardson, Charlotte L, Gray, Laura J, Poulin, Benoit, Waheed, Ghazala et al (show 7 more authors)
(2022)
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial.
DIABETES OBESITY & METABOLISM, 24 (8).
pp. 1509-1521.